Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery 2016

Sir Tom Blundell's Biography



Sir Tom Blundell, Professor, University of Cambridge

Tom Blundell is Sir William Dunn Professor of Biochemistry and Head of Biological Sciences in the University of Cambridge. He researches on structural biology of cell regulation, structural bioinformatics and applications to drug discovery and medicine. He is Member of Academia Europaea, Fellow of the Royal Society and Fellow of Academy of Medical Sciences. He has Honorary Doctorates from fifteen universities. He was a member of ACOST, the advisory group to the PM in the 1980s, founding CEO BBSRC in 1990s and Chairman of the Royal Commission on Environmental Pollution 1998 to 2005. He co-founded Astex Therapeutics, he was Non-Executive Director of Celltech from 1996 to 2005 and has been science advisor to Pfizer, UCB and SKB.

Sir Tom Blundell Image

Understanding And Combating Mutations In Genetic Disease And Drug Resistance: Different Challenges But Common Solutions

Wednesday, 23 March 2016 at 09:30

Add to Calendar ▼2016-03-23 09:30:002016-03-23 10:30:00Europe/LondonUnderstanding And Combating Mutations In Genetic Disease And Drug Resistance: Different Challenges But Common SolutionsAcademic Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com

Mutations in genetic disease and the emergence of resistance in pathogens can manifest themselves through changes in thermal stability of proteins, and interactions with other proteins and ligands. Understanding these mechanisms can give clues about the use of existing drugs and design of new ones.


Add to Calendar ▼2016-03-22 00:00:002016-03-23 00:00:00Europe/LondonAcademic Drug Discovery 2016Academic Drug Discovery 2016 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com